Sort
48,018 grants matching “immunotherapy”
ADULT AIDS CLINICAL TRIALS UNIT
$1,909,378Ohio State University · U01 · FY2000 · AI
Biology and Therapy of High Risk Neuroblastoma
$1,909,108Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2006 · CA
Transplant Tolerance in Non-Human Primates
$1,908,381Christian P Larsen · Emory University · U19 · FY2011 · AI
Biology and Therapy of High Risk Neuroblastoma
$1,908,071Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2008 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$1,907,385Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,907,279David J Odde · University Of Minnesota · P01 · FY2025 · CA
Project 4:Targeting M2-like Macrophages and MDSC with Myelolytic-Virotherapy
$1,907,013Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
Enhancing T Cell Therapy of Cancer
$1,905,870Helen E Heslop · Baylor College Of Medicine · P01 · FY2008 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,905,452E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2018 · CA
Clinical Research Correlatives Core
$1,904,916Kaska Wloka · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
THERAPY OF CML
$1,903,897University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
COLORADO ADULT AIDS CLINICAL TRIALS UNIT
$1,903,131University Of Colorado Denver · U01 · FY2003 · AI
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,902,504Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2011 · CA
Dendritic cells heterogeneity and function
$1,902,017Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu
$1,901,909Forest M White · Massachusetts Institute Of Technology · U54 · FY2024 · CA
SPORE In Prostate Cancer
$1,901,414Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2011 · CA
SPORE In Prostate Cancer
$1,901,412Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2015 · CA
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
$1,901,409Nicholas J Mantis · Nysdoh/Health Research, Inc. · N01 · FY2020 · AI
Biology and Therapy of High Risk Neuroblastoma
$1,899,503Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2007 · CA
Developmental Funds
$1,899,206Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2015 · CA
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
$1,898,361Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2021 · CA
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
$1,897,572Margaret M Madeleine · Fred Hutchinson Cancer Center · U54 · FY2023 · CA
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,897,094Ohio State University · P01 · FY2004 · CA
DNA Vaccines
$1,897,092George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Immunotherapy for Ocular Surface Diseases
$1,896,481Sandeep Jain · University Of Illinois At Chicago · R24 · FY2024 · EY